Regen Biopharma Inc
RGBP
Revenue
31.64k
0.000.00%
3 Months ChangeAssets
170.15k
▲29.38k▲20.87%
3 Months ChangeLiabilities
5.33M
▲11.13k▲0.2093%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-18
Form 8-K
ID: 0001493152-24-037011
2024-09-13
Form 8-K
ID: 0001493152-24-036161
2024-08-13
Form 10-Q
ID: 0001607062-24-000238
2024-05-29
Form 8-K
ID: 0001607062-24-000219
2024-05-23
Form 8-K
ID: 0001607062-24-000211
2024-05-10
Form 8-K
ID: 0001607062-24-000175
2024-04-29
Form 8-K
ID: 0001607062-24-000150
2024-04-24
Form 10-Q
ID: 0001607062-24-000131
2024-02-09
Form 8-K
ID: 0001607062-24-000053
2024-01-19
Form 10-Q
ID: 0001607062-24-000033